Two Sigma Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
6,064
+944
+18% +$181K 0.15% 125
2026
Q1
$850K Sell
5,120
-5,516
-52% -$905K 0.1% 261
2025
Q4
$1.7M Sell
10,636
-699
-6% -$96K 0.23% 86
2025
Q3
$1.06M Buy
+11,335
New +$801K 0.16% 147
2025
Q1
Sell
-3,593
Closed -$323K 1871
2024
Q4
$323K Buy
+3,593
New +$423K 0.04% 597
2024
Q3
Sell
-3,657
Closed -$415K 3288
2024
Q2
$415K Buy
3,657
+1,342
+58% +$144K 0.01% 1707
2024
Q1
$307K Buy
+2,315
New +$302K ﹤0.01% 1940
2022
Q4
Sell
-1,509
Closed -$212K 2954
2022
Q3
$212K Buy
1,509
+101
+7% +$18.5K 0.01% 1908
2022
Q2
$190K Buy
+1,408
New +$240K 0.01% 1669
2019
Q1
Sell
-328
Closed -$216K 2177
2018
Q4
$216K Buy
+328
New +$344K ﹤0.01% 1650
2018
Q1
Sell
-732
Closed -$1.14M 2830
2017
Q4
$1.14M Buy
+732
New +$1.12M 0.03% 388
2017
Q3
Sell
-206
Closed -$260K 1082
2017
Q2
$260K Buy
+206
New +$208K 0.05% 413
2016
Q3
Sell
-677
Closed -$382K 730
2016
Q2
$382K Buy
+677
New +$424K 0.21% 141

Other funds holding LABU

Two Sigma Securities's LABU Position: Q2 2026 in Review

Two Sigma Securities increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 18% in Q2 2026, buying an estimated $181K and bringing the position to 6,064 shares worth $1.77M. The position accounts for 0.15% of the portfolio, ranked #125.

Two Sigma Securities first reported a position in LABU in Q2 2016 and has held it in 13 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Two Sigma Securities held 6,064 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.77M as of Q2 2026.
  • Two Sigma Securities bought 944 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $181K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.15% of Two Sigma Securities's portfolio in Q2 2026, its #125 holding.
  • Two Sigma Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and has held it in 13 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.